https://www.marketscreener.com/quote/stock/BEIGENE-LTD-26123632/news/BeiGene-Announces-New-Efficacy-Analysis-Comparing-BRUKINSA-vs-Acalabrutinib-in-Relapsed-or-Refractor-46074386/?utm_source=telegram&utm_medium=social&utm_campaign=share